Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.
Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.
In this episode, Diana Isaacs, PharmD, BCPS, BCACP, CDCES, BC-ADM, FADCES, FCCP, and Joshua J. Neumiller, PharmD, CDCES, FADCES, FASCP, discuss the use of mineralocorticoid receptor antagonists in patients with chronic kidney disease and type 2 diabetes, including:
Endocrine Clinical Pharmacy Specialist
CGM and Remote Monitoring Program Coordinator
Endocrinology and Metabolism Institute
Vice Chair & Allen I. White Distinguished Professor
Department of Pharmacotherapy
College of Pharmacy and Pharmaceutical Sciences
Washington State University
This program has been made available online.
Experts discuss practical use of CGM in clinical practice, with a focus on overcoming barriers to integration, from Clinical Care Options (CCO)
Clinical Care Options (CCO) presents Dr. Jane Jeffrie Seley discussing the importance of patient education and training when managing T2D treatment in older patients
Expert faculty insight on evidence for finerenone use in DKD, selecting patients for therapy, overcoming clinical inertia, from ProCE
Downloadable slides on CGM use in clinical practice, with a focus on overcoming barriers to integration, from Clinical Care Options (CCO)